Clinical Trial Update: Extracellular RNA Biomarkers of Myotonic Dystrophy

View source ↗

Summary

This update notes that a study evaluating extracellular RNA biomarkers in myotonic dystrophy is currently recruiting at Massachusetts General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myotonic Dystrophy | Status: RECRUITING